# UK Organ Preservation Market > UK Organ Preservation Market Research Report By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage), By Organ Type (Kidney, Liver, Heart, Lungs) and By End User (Hospitals & Clinics, Organ Banks) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.62% - **2024:** $ 15.19 Million - **2025:** $ 16.2 Million - **2035:** $ 30.74 Million - **Key Players:** Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Baxter International (US), Medtronic (US), NantKwest (US) **Report ID:** MRFR/MED/47699-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-organ-preservation-market-49450 --- ## Market Summary ## **UK Organ Preservation Market Overview** As per MRFR analysis, the UK Organ Preservation Market Size was estimated at 12.05 (USD Million) in 2023. The UK Organ Preservation Market Industry is expected to grow from 12.75(USD Million) in 2024 to 30.92 (USD Million) by 2035. The UK Organ Preservation Market CAGR (growth rate) is expected to be around 8.387% during the forecast period (2025 - 2035). ### **Key UK Organ Preservation Market Trends Highlighted** The UK Organ Preservation Market is witnessing significant trends primarily driven by advancements in preservation technology. The increasing demand for organ transplants is a crucial market driver, propelling the need for more efficient organ preservation solutions. Hospitals and research institutions are recognizing the importance of extending organ viability through innovative preservation techniques, which improves transplant outcomes. The UK government has been actively promoting organ donation initiatives, thereby increasing public awareness and acceptance of organ transplants. This supportive policy environment is helping to drive growth in the organ preservation segment. Additionally, there are various opportunities to be explored, such as improving preservation solutions to enhance the storage time and functionality of organs. Collaborations between biotech firms and healthcare providers are on the rise, as they aim to develop better preservation methods that ensure organs remain viable for transplant longer. The rise of personalized medicine also opens avenues for tailored preservation techniques that meet specific patient needs. Recent times have shown a trend toward the integration of digital solutions in organ preservation, including monitoring technologies that track organ conditions during transit. The incorporation of AI and data analytics is transforming how organ preservation practices are approached, making it easier to predict and manage organ health during transportation. As the focus on patient-centric healthcare continues to grow, these innovative advancements are likely to have a lasting impact on the UK organ preservation market and the overall healthcare landscape. The UK's commitment to improving organ donation and transplantation processes will continue to shape emerging trends in this sector. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **UK Organ Preservation Market Drivers** ### **Increasing Demand for Organ Transplants** One of the main factors propelling the UK organ preservation market is the rising number of patients in need of organ transplants. According to NHS Blood and Transplant, there are reportedly more than 6,000 people on the UK's transplant waiting list at the moment. In order to prolong the viability of donated organs and raise transplant success rates, this circumstance is creating an urgent demand for effective organ preservation methods. Advanced organ preservation techniques are in greater demand as a result of organizations like the NHS actively seeking to improve transplantation procedures. Given that the number of organ transplant procedures is expected to rise by at least 3% a year, the UK organ preservation market is expected to develop significantly as a result of this growing demand. ### **Technological Advancements in Preservation Methods** Innovations in preservation technology significantly contribute to the growth of the UK Organ Preservation Market Industry. The introduction of machine perfusion technology enhances organ viability and function pre-transplant. For instance, research funded by the Medical Research Council in the UK has shown that machine perfusion can improve the outcomes of kidney transplants by up to 20%. This drives interest and investment from institutions such as the Royal College of Surgeons, which supports ongoing Research and Development (R&D) initiatives in this area. The advances in technology lead to higher adoption rates among hospitals, fostering growth in the organ preservation sector. ### **Supportive Government Policies and Initiatives** The UK government promotes initiatives aimed at increasing organ donation rates, significantly impacting the UK Organ Preservation Market Industry. The introduction of the Organ Donation (Deemed Consent) Act in 2020 has similar legislative changes that led to a rise in organ donation registrations by approximately 33% in the first year alone, as reported by NHS Blood and Transplant. This increase necessitates more advanced organ preservation solutions to ensure that a larger number of organs can be successfully utilized, thus driving market growth. The government’s commitment to improving transplant rates underlines the importance of effective organ preservation methods. ## **UK Organ Preservation Market Segment Insights** ### **Organ Preservation Market Solution Insights** The UK Organ Preservation Market, particularly within the Solution segment, plays a critical role in ensuring the viability of organs for transplantation, contributing significantly to the healthcare landscape. The various solutions employed in organ preservation are vital as they enhance the durability of harvested organs, allowing for better outcomes post-transplantation. The University of Wisconsin Solution is widely utilized in the preservation of organs, specifically kidneys, due to its balanced formulation that effectively maintains cellular integrity throughout the transportation process. Custodial HTK is favored for its ability to extend preservation times for hearts and livers, making it a crucial component in high-urgency transplant scenarios where time is critical. Collins Solution is also prominent within the UK market, known for its effectiveness in liver preservation, which has led to improvements in organ transplant success rates. Celsior Solution has emerged for its biocompatibility and effectiveness across various organ types, showcasing innovation in organ conservation practices. Perfadex solution is recognized for its role in preserving lungs, a complex organ that demands precision in its preservation to ensure compatibility and functionality after transplantation. Finally, Citrate Solution has its niche in liver preservation, offering another option for ensuring organ longevity, reflecting the diverse needs of organ transplant teams. Overall, the Solution segment in the UK Organ Preservation Market showcases a series of specialized formulations that address the critical requirements of different organ preservation needs, each solution contributing to the overarching goals of enhancing transplant success and patient outcomes. The market is witnessing robust growth driven by advancements in technology, the increasing prevalence of organ transplants, and growing awareness of the importance of organ preservation, all of which highlight the significance of these solutions. This segment mirrors larger trends in the healthcare industry as practitioners seek out innovative methods to improve organ transport efficiency, ultimately aiming to reduce wait times and increase the number of successful transplantation procedures in the UK. Furthermore, with the collaboration among healthcare institutions and continuous Research and Development in the field, the market seems poised for further advancements that will undoubtedly shape the future of organ preservation strategies. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Organ Preservation Market Preservation Techniques Insights** The Preservation Techniques segment within the UK Organ Preservation Market plays a crucial role in ensuring the viability of organs for transplant. This segment primarily encompasses methods such as Static Cold Storage and Dynamic Cold Storage, which are essential for maintaining organ integrity prior to surgical procedures. Static Cold Storage is widely utilized due to its simplicity and efficiency in organ preservation, offering a reliable option during transportation and storage. Conversely, Dynamic Cold Storage has gained prominence as it effectively enhances organ quality through active cooling, contributing significantly to organ health. As the demand for organ transplants continues to rise in the UK, driven by an aging population and increasing rates of chronic diseases, the need for advanced preservation techniques becomes even more pertinent. Relevant statistics indicate that improved preservation methods can lead to better transplant outcomes, thereby reinforcing the importance of innovation in this field. The advancements in technology and techniques targeted at organ preservation have become vital growth drivers in the UK Organ Preservation Market, highlighting opportunities for further Research and Development in techniques that can maximize organ availability and functionality. This evolving landscape reveals the potential for improved health outcomes for patients relying on organ transplants. ### **Organ Preservation Market Organ Type Insights** The UK Organ Preservation Market is significantly shaped by various organ types including Kidney, Liver, Heart, and Lungs, each playing a crucial role in the landscape of organ transplantation and preservation. Kidneys stand out as they are among the most commonly transplanted organs, underscoring their importance in addressing renal failure in the UK. The Liver segment also commands attention due to the increasing prevalence of liver diseases, driving demand for effective preservation methods. The Heart segment, though more challenging to preserve due to its sensitivity, is vital given the high incidence of cardiovascular diseases across the UK population. Lungs, essential for respiratory function, are often at risk due to conditions like chronic obstructive pulmonary disease (COPD) and other pulmonary ailments, further spotlighting the need for advancements in lung preservation techniques. Overall, the diversification within the Organ Type segmentation reflects the complexities of organ transplantation and the ongoing efforts to enhance outcomes for recipients, highlighting both the opportunities and challenges within the UK Organ Preservation Market for future growth and innovation. This robust structure enables the market to respond to varying patient needs while aligning with government health initiatives aimed at improving organ donation and transplantation processes in the UK. ### **Organ Preservation Market End User Insights** The UK Organ Preservation Market is intricately segmented by End User, which primarily includes Hospitals and Clinics as well as Organ Banks. These entities play a vital role in the organ preservation ecosystem, with Hospitals and Clinics facilitating the surgical procedures necessary for organ transplants and often employing advanced preservation techniques to enhance the viability of donated organs. Organ Banks, on the other hand, are responsible for the collection, storage, and distribution of donated organs, ensuring that they are preserved under optimal conditions for future transplantation. The increasing demand for organ transplants in the UK, driven by a growing population and rising chronic diseases, underscores the significance of these establishments in maintaining effective organ preservation protocols. Technological advancements in preservation methods, alongside regulatory support from health authorities, further bolster the capabilities of these End Users. As they work together to provide life-saving interventions, Hospitals and Clinics, along with Organ Banks, consistently contribute to improving patient outcomes in transplantation, thus reinforcing their dominating role in the UK's organ preservation landscape. ## **UK Organ Preservation Market Key Players and Competitive Insights** The UK Organ Preservation Market is an essential segment of the healthcare industry, focusing on the methodologies and technologies that ensure the viability and transportation of organs for transplantation. As the demand for organ transplants continues to rise, driven by increasing awareness about organ donation and the prevalence of chronic diseases, the competitive landscape in this market is becoming increasingly dynamic. Businesses operating within this sphere are innovating continuously to enhance preservation techniques, thereby extending the lifespan and functionality of organs during transport. These advances are crucial not only for improving patient outcomes but also for optimizing the logistics of organ transplantation. The UK market is characterized by a blend of established players and innovative startups, each striving to leverage their strengths in technology, research, and partnerships to capture market share and deliver solutions that meet the evolving needs of transplant centers and healthcare professionals. Brammer BioScience has established a notable presence in the UK's organ preservation scene, capitalizing on its extensive experience and expertise within the biopharmaceutical industry. The company has garnered recognition for its innovative solutions designed to improve organ viability during transportation. One of the key strengths of Brammer BioScience lies in its robust research and development capabilities. The company invests significantly in developing advanced preservation technologies and offers tailored solutions that cater to the unique needs of various types of organs. This focus on customization enables Brammer BioScience to foster strong relationships with healthcare providers, thereby increasing its footprint in the UK market. Furthermore, the company's commitment to quality and regulatory compliance enhances its reputation, making it a preferred partner for organ preservation needs. TransMedics is another key player in the UK Organ Preservation Market, known for its cutting-edge technologies that significantly improve organ viability and transplantation outcomes. The company’s flagship products, such as the Organ Care System, stand at the forefront of innovation, allowing for dynamic preservation of organs by simulating physiological conditions. This technology is particularly beneficial for heart and lung transplants, giving TransMedics a considerable edge. The company maintains a robust presence in the UK, supported by strategic partnerships with healthcare institutions that facilitate widespread adoption of its solutions. Furthermore, TransMedics has been active in mergers and acquisitions, augmenting its portfolio and expanding its reach within the market. These strategic moves, combined with a focus on advancing organ preservation technologies, underscore the company's strengths and position in the competitive landscape of the UK organ preservation sector. ### **Key Companies in the UK Organ Preservation Market Include** ## **UK Organ Preservation Market Industry Developments** The UK Organ Preservation Market has recently seen significant developments, particularly in advancements related to organ preservation technologies and methodologies. Companies like Brammer BioScience, TransMedics, and XVivo Perfusion have been actively engaged in enhancing preservation techniques to improve transplant success rates. In terms of mergers and acquisitions, no notable mergers were reported regarding the specified companies in recent months; however, ongoing collaborations and partnerships are prevalent within the sector to foster innovation. Market growth has been instrumental, driven by increased public awareness and technological advancements, leading to a positive shift in organ preservation practices. As of March 2023, Medtronic announced new initiatives to enhance organ viability during transportation, which reflects an adaptive strategy in response to growing demand. Furthermore, the LifeLine Scientific organization has made strides in expanding its distribution capabilities within the UK, aiming to tackle the challenges of organ shortage. This market segment has also witnessed a steady rise in governmental support for transplant research, highlighting the UK’s commitment to improving healthcare outcomes associated with organ transplantation and preservation. ## **UK Organ Preservation Market Segmentation Insights** ### **Organ Preservation Market Solution Outlook** ### **Organ Preservation Market Preservation Techniques Outlook** ### **Organ Preservation Market Organ Type Outlook** ### **Organ Preservation Market End User Outlook** ## Market Drivers ### Increasing Demand for Transplants The rising demand for organ transplants in the UK is a primary driver of the organ preservation market. As the population ages and the prevalence of chronic diseases increases, the need for organ transplants is expected to grow. According to NHS statistics, the number of patients waiting for organ transplants has reached over 6,000, highlighting a significant gap between supply and demand. This situation necessitates effective organ preservation techniques to ensure that harvested organs remain viable for transplantation. The organ preservation market is thus positioned to expand as healthcare providers seek innovative solutions to enhance organ viability and improve transplant success rates. ### Government Initiatives and Funding Government initiatives aimed at increasing organ donation rates are significantly impacting the organ preservation market. The UK government has implemented various campaigns to raise awareness about organ donation, which has led to a rise in registered donors. Additionally, funding for research into organ preservation techniques has been bolstered, with public health organizations allocating resources to improve preservation methods. This support from the government enhances the organ preservation market by fostering innovation and ensuring that new technologies are developed and implemented effectively. As a result, the market is likely to benefit from increased funding and public awareness initiatives. ### Growing Awareness of Organ Donation Public awareness regarding the importance of organ donation is a crucial driver for the organ preservation market. Educational campaigns and advocacy efforts have led to a more informed population, resulting in an increase in the number of individuals willing to donate their organs. This heightened awareness is essential for addressing the organ shortage crisis in the UK. The organ preservation market stands to gain from this trend, as more organs become available for transplantation, necessitating advanced preservation techniques to maintain organ viability. The interplay between public awareness and organ preservation solutions is likely to shape the future landscape of the market. ### Advancements in Preservation Technologies Technological innovations in organ preservation methods are transforming the organ preservation market. Techniques such as hypothermic machine perfusion and normothermic perfusion are gaining traction, offering improved outcomes for organ viability. These advancements not only extend the preservation time of organs but also enhance their functionality post-transplant. The organ preservation market is witnessing increased investment in research and development, with the aim of creating more efficient preservation solutions. As hospitals and transplant centers adopt these cutting-edge technologies, the market is likely to experience substantial growth, driven by the need for better preservation methods that can lead to higher transplant success rates. ### Collaboration Between Healthcare Institutions Collaboration among healthcare institutions is fostering advancements in the organ preservation market. Partnerships between hospitals, research institutions, and biotechnology companies are facilitating the sharing of knowledge and resources, leading to the development of innovative preservation techniques. These collaborations often result in clinical trials and research studies that enhance the understanding of organ preservation methods. The organ preservation market benefits from these synergies, as they promote the adoption of best practices and cutting-edge technologies. As more institutions work together to improve organ preservation, the market is expected to grow, driven by collective efforts to enhance transplant outcomes. ## Future Outlook The [Organ Preservation Market](https://www.marketresearchfuture.com/reports/organ-preservation-market-6073) is projected to grow at 6.62% CAGR from 2025 to 2035, driven by technological advancements, increasing organ transplant demand, and enhanced preservation techniques. **New opportunities:** - Development of advanced hypothermic preservation solutions for extended organ viability. - Implementation of AI-driven logistics for optimized organ transport and allocation. - Partnerships with hospitals for integrated organ preservation and transplantation services. By 2035, the organ preservation market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Solution: University of Wisconsin Solution (Largest) vs. Custodial HTK (Fastest-Growing) In the UK organ preservation market, the University of Wisconsin Solution continues to dominate, holding a significant market share due to its established efficacy in preserving organs for transplantation. Following closely is the Custodial HTK solution, which is gaining traction among healthcare providers for its innovative preservation capabilities. Growth trends in this segment are influenced by advancing medical technologies and the rising demand for organ transplants. The Custodial HTK solution is considered a game changer, with healthcare professionals increasingly recognizing its benefits, thus driving its rapid adoption. Additionally, collaborations between medical institutions and solution providers are enhancing the development and availability of these preservation solutions in the market. University of Wisconsin Solution (Dominant) vs. Custodial HTK (Emerging) The University of Wisconsin Solution has established itself as the dominant player in the UK organ preservation market, primarily due to its proven ability to maintain organ viability during transport and reduce ischemic injury. This solution leverages a unique formulation that has been extensively tested and is widely accepted by transplant centers. Conversely, Custodial HTK is an emerging solution noted for its innovative properties that promote superior organ preservation compared to traditional methods. Its growing popularity among surgeons and medical professionals is leading to increased usage, establishing it as a feasible alternative for specific transplant scenarios. Both solutions have distinct advantages, with ongoing research and clinical trials continually assessing their effectiveness and expanding their applications. ### By Preservation Techniques: Static Cold Storage (Largest) vs. Dynamic Cold Storage (Fastest-Growing) In the UK organ preservation market, Static Cold Storage holds the largest market share, primarily due to its established presence and reliability in preserving organs over extended periods. This technique has been the standard in organ transplant procedures, cementing its dominance in the sector. On the other hand, Dynamic Cold Storage is emerging rapidly, gaining traction as an innovative alternative that promises enhanced preservation capabilities compared to traditional methods. The growth trends in the preservation techniques segment are driven by advancements in technology and increasing healthcare demands. Dynamic Cold Storage, in particular, is positioned as the fastest-growing segment, fueled by its ability to maintain organ viability for longer durations and improve transplant success rates. This innovative method presents new opportunities for healthcare facilities, contributing to an overall shift towards more efficient preservation techniques in the UK organ preservation market. Static Cold Storage (Dominant) vs. Dynamic Cold Storage (Emerging) Static Cold Storage is recognized for its reliability and efficiency, making it the dominant preservation method in the UK organ preservation market. It involves storing organs at a low temperature, ensuring their viability for transplantation. This technique has been widely adopted across healthcare institutions due to its simplicity and effectiveness. In contrast, Dynamic Cold Storage represents an emerging trend that utilizes advanced technologies to enhance organ preservation. This method not only increases the shelf life of organs but also improves their quality for transplantation, thereby addressing the growing need for effective preservation solutions. Such innovation is increasingly appealing to medical practitioners, as it aligns with the evolving demands of organ transplantation. ### By Organ Type: Kidney (Largest) vs. Liver (Fastest-Growing) In the UK organ preservation market, the distribution of market share among different organ types reveals that the Kidney segment is the largest, commanding a significant portion of the market. The Liver segment, while smaller in comparison, is showing promising growth, attracting increasing attention from healthcare professionals and hospitals due to its critical importance in transplantation efforts. Growth trends indicate that advancements in preservation techniques are driving the expansion of both the Kidney and Liver segments. The Kidney segment continues to benefit from robust demand and established protocols, while the Liver segment is emerging rapidly, supported by innovations in preservation solutions and a rising number of liver transplantations driven by better awareness and screening processes. Kidney (Dominant) vs. Liver (Emerging) The Kidney segment dominates the UK organ preservation market due to the prevalence of kidney disorders and the importance of timely transplantation. Its well-established preservation methods ensure longevity and viability, making it a preferred choice for organ transplantations. In contrast, the Liver segment is considered emerging, spurred by innovative preservation techniques that enhance organ viability post-harvesting. This segment is gaining traction thanks to increased awareness of liver diseases and an uptick in transplantation activities, coupled with research advancements that optimize liver organ storage solutions, making it a key player in the future landscape of organ preservation. ### By End-User: Hospitals & Clinics (Largest) vs. Organ Banks (Fastest-Growing) In the UK organ preservation market, Hospitals & Clinics represent the largest segment, accounting for a significant share due to their extensive infrastructure and high patient demand. Organ Banks, while smaller in overall market share, are rapidly gaining ground, driven by increased awareness and advancements in preservation techniques. These dynamics are shaping the competitive landscape, with Hospitals & Clinics leaning towards comprehensive solutions that cater to their operational needs. The growth trends within these segments indicate a robust trajectory for Organ Banks as they emerge as innovators in the field. The increasing incidence of organ transplants, alongside favorable regulatory frameworks, is propelling Organ Banks into a position of prominence. Meanwhile, Hospitals & Clinics are evolving, focusing on efficiency and collaboration with organ preservation specialists, ensuring better outcomes and streamlined processes for patients requiring transplants. This interplay between segments creates a vibrant marketplace characterized by both competition and collaboration. Hospitals & Clinics (Dominant) vs. Organ Banks (Emerging) Hospitals & Clinics are the dominant players in the UK organ preservation market, characterized by their established protocols, extensive patient networks, and integrated healthcare systems that facilitate organ retrieval and transplantation. These facilities are equipped with advanced technologies and trained personnel to ensure optimal organ preservation practices. In contrast, Organ Banks are emerging as key contributors, focusing on specialized preservation techniques and inventory management to meet the increasing demand for organs. The collaboration between these two segments enhances the efficiency of organ donation and transplantation processes, as Hospitals & Clinics rely on Organ Banks for timely access to preserved organs, ensuring the best possible outcomes for patients in need. ## Competitive Benchmarking The organ preservation market is currently characterized by a dynamic competitive landscape, driven by advancements in technology, increasing demand for organ transplants, and a growing emphasis on improving organ viability. Key players such as Organ Recovery Systems (US), TransMedics (US), and Xvivo Perfusion (SE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Organ Recovery Systems (US) focuses on innovation in preservation solutions, while TransMedics (US) emphasizes the development of its Organ Care System, which allows for the preservation of organs in a near-physiological state. Xvivo Perfusion (SE) is also innovating with its perfusion technology, which is designed to improve organ quality and extend preservation times. Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological advancements and operational efficiencies.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the organ preservation market appears moderately fragmented, with several key players exerting influence. This fragmentation allows for a variety of approaches to organ preservation, fostering innovation and competition among firms. The collective influence of these companies shapes market dynamics, as they strive to differentiate themselves through unique offerings and improved service delivery. In October TransMedics (US) announced a strategic partnership with a leading transplant center in the UK to enhance the clinical application of its Organ Care System. This collaboration is expected to facilitate the adoption of their technology, potentially increasing the number of viable organs available for transplantation. The strategic importance of this partnership lies in its potential to improve patient outcomes and expand the market reach of TransMedics, thereby reinforcing its competitive position. In September Xvivo Perfusion (SE) launched a new version of its perfusion system, which incorporates advanced monitoring capabilities. This innovation is aimed at providing real-time data on organ conditions during preservation, which could significantly enhance decision-making for transplant surgeons. The introduction of this technology underscores Xvivo's commitment to improving organ viability and aligns with the broader trend of integrating digital solutions into healthcare. In August Organ Recovery Systems (US) expanded its product line by introducing a new preservation solution specifically designed for pediatric organs. This move not only addresses a critical need in the market but also positions the company as a leader in specialized organ preservation. The strategic importance of this expansion is evident in its potential to capture a niche market segment, thereby enhancing the company's overall market share. As of November current trends in the organ preservation market include a strong focus on digitalization, sustainability, and the integration of artificial intelligence (AI) into preservation techniques. Strategic alliances are increasingly shaping the competitive landscape, as companies collaborate to leverage complementary strengths. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize research and development, alongside sustainable practices, will be better positioned to thrive in the future. ## Recent News & Developments The UK Organ Preservation Market has recently seen significant developments, particularly in advancements related to organ preservation technologies and methodologies. Companies like Brammer BioScience, TransMedics, and XVivo Perfusion have been actively engaged in enhancing preservation techniques to improve transplant success rates. In terms of mergers and acquisitions, no notable mergers were reported regarding the specified companies in recent months; however, ongoing collaborations and partnerships are prevalent within the sector to foster innovation. Market growth has been instrumental, driven by increased public awareness and technological advancements, leading to a positive shift in organ preservation practices. As of March 2023, Medtronic announced new initiatives to enhance organ viability during transportation, which reflects an adaptive strategy in response to growing demand. Furthermore, the LifeLine Scientific organization has made strides in expanding its distribution capabilities within the UK, aiming to tackle the challenges of organ shortage. This market segment has also witnessed a steady rise in governmental support for transplant research, highlighting the UK’s commitment to improving healthcare outcomes associated with organ transplantation and preservation. ## Report Scope | MARKET SIZE 2024 | 15.19(USD Million) | | --- | --- | | MARKET SIZE 2025 | 16.2(USD Million) | | MARKET SIZE 2035 | 30.74(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.62% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Baxter International (US), Medtronic (US), NantKwest (US) | | Segments Covered | Solution, Preservation Techniques, Organ Type, End-User | | Key Market Opportunities | Advancements in preservation techniques enhance organ viability, driving demand in the organ preservation market. | | Key Market Dynamics | Technological advancements in organ preservation techniques drive competitive dynamics and regulatory adaptations in the UK market. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What was the overall valuation of the UK organ preservation market in 2024?** A: The overall market valuation was $15.19 Million in 2024. **Q: What is the projected market valuation for the UK organ preservation market by 2035?** A: The projected valuation for 2035 is $30.74 Million. **Q: What is the expected CAGR for the UK organ preservation market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 6.62%. **Q: Which companies are considered key players in the UK organ preservation market?** A: Key players include Organ Recovery Systems, TransMedics, Xvivo Perfusion, LifeLink Foundation, Tissue Regenix, Baxter International, Medtronic, and NantKwest. **Q: What are the main segments of the UK organ preservation market?** A: The main segments include Solutions, Preservation Techniques, Organ Type, and End-User. **Q: What was the valuation of the Static Cold Storage segment in 2024?** A: The valuation for the Static Cold Storage segment was $6.07 Million in 2024. **Q: How much is the Dynamic Cold Storage segment projected to be worth by 2035?** A: The Dynamic Cold Storage segment is projected to reach $18.49 Million by 2035. **Q: What is the valuation range for the Kidney organ type segment in 2024?** A: The valuation range for the Kidney organ type segment was $3.5 Million to $7.1 Million in 2024. **Q: What is the expected valuation for the Hospitals & Clinics end-user segment by 2035?** A: The expected valuation for the Hospitals & Clinics end-user segment by 2035 is $18.54 Million. **Q: What are the projected values for the Perfadex solution segment in 2024?** A: The projected values for the Perfadex solution segment ranged from $3.0 Million to $6.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-organ-preservation-market-49450*